Research in Pharmaceutical Sciences · 2019 · 23 citations · 21 references
PharmacyPharmaceuticsPharmacokineticsBioavailabilityDrug DeliveryNanoparticle Drug DeliveryDrug EncapsulationNanocarriers For TherapeuticsNanomedicineNanoparticle Delivery SystemsNanoparticle DesignNanoparticle FormulationsChitosan NanocarriersCirculationDrug Delivery NanocarriersNanoparticle-mediated Bioavailability EnhancementNephrotic Syndrome TreatmentPharmacokinetic EnhancementPoly(lactic-co-glycolic Acid)Poly(lactic-co-glycolic Acid) Nanoparticles
pharmacokinetic study showed 2.6, 3.10, and 4.30 folds enhancement in relative availability of FSM for FSM-PLGA, FSM-chitosan-coated-PLGA and FSM-chitosan-conjugated- PLGA nanoparticles, respectively than FSM. The present research work concluded that FSM loaded chitosan conjugated PLGA nanoparticles could enhance the systemic circulation of FSM with improved pharmacokinetics parameters.
21